Intelligence Β· Patent portfolio
Chongqing Precision Biotech Patents
Full USPTO pharma patent portfolio for Chongqing Precision Biotech β grant dates, expiration, and drug cross-links.
- Patents
- 158
- Expiring β€24m
- 2
Quick answer
Chongqing Precision Biotech has 158 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β use filters for patent-cliff planning.
-
US 8165643
Charging cradle
granted -
US 8123541
Electrical connector with expanded cover
granted -
US 8058025
Methods for determining efficacy of chemotherapeutic agents
granted -
US 7892008
Electrical connector having metallic lock
granted -
US 7771963
Methods for determining efficacy of chemotherapeutic agents
granted -
US 7678552
Method for selecting therapeutic agents for cancer treatment
granted -
US 7563593
Method for preparing cell cultures from biological specimens for assaying secreted factors
granted -
US 7501260
Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment
granted -
US 7410363
Electrical connector having compliant biasing device
granted -
US 7314731
Method for selecting therapeutic agents for cancer
granted -
US 7112415
Method of preparing cell cultures from biological specimens for assaying a response to an agent
granted -
US 6933129
Method for culturing and assaying cells
expired -
US 6900027
Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
expired -
US 6887680
Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
expired
Frequently asked questions
How many patents does Chongqing Precision Biotech have?
158 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Chongqing Precision Biotech patents expire?
2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory